W67-20329-34653
4 vaccinations
0 coded responses
6 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 112 / NY
- Registered
- 2022-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Dose 2 — Pfizer-BioNTech
-
2021-12-21
Dose 3 — Pfizer-BioNTech
-
2022-12-21
Dose 4 — Moderna
-
2022-12-24
Registered in v-safe
-
2022-12-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-12-30
- 2023-01-06
- 2023-01-13
- 2023-01-20
- 2023-01-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | No |
| 2 | 2021-04-05 | Pfizer-BioNTech | No |
| 3 | 2021-12-21 | Pfizer-BioNTech | No |
| 4 | 2022-12-21 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.